Journal of Alzheimer's Disease

The Journal of Alzheimer's Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, hypotheses, ethics reviews, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer's disease.

Publisher
IOS Press
History
1998-present
Website
http://www.j-alz.com/
Impact factor
3.920 (2016)

Some content from Wikipedia, licensed under CC BY-SA

Alzheimer's disease & dementia

Can lithium halt progression of Alzheimer's disease?

There remains a controversy in scientific circles today regarding the value of lithium therapy in treating Alzheimer's disease. Much of this stems from the fact that because the information gathered to date has been obtained ...

Alzheimer's disease & dementia

Is there a link between lifetime lead exposure and dementia?

To the medical community's surprise, several studies from the US, Canada, and Europe suggest a promising downward trend in the incidence and prevalence of dementia. Important risk factors for dementia, such as mid-life obesity ...

Alzheimer's disease & dementia

Exercise could slow withering effects of Alzheimer's

Exercising several times a week may delay brain deterioration in people at high risk for Alzheimer's disease, according to a study that scientists say merits further research to establish whether fitness can affect the progression ...

Alzheimer's disease & dementia

Hypothesis underpinning dementia research 'flawed'

A hypothesis which has been the standard way of explaining how the body develops Alzheimer's Disease for almost 30 years is flawed, according to a University of Manchester biologist.

Alzheimer's disease & dementia

New study highlights Alzheimer's herpes link, experts say

A new commentary by scientists at the Universities of Manchester and Edinburgh on a study by Taiwanese epidemiologists supports the viability of a potential way to reduce the risk of Alzheimer's disease.

Alzheimer's disease & dementia

Neuroscientists say daily ibuprofen can prevent Alzheimer's disease

A Vancouver-based research team led by Canada's most cited neuroscientist, Dr. Patrick McGeer, has successfully carried out studies suggesting that, if started early enough, a daily regimen of the non-prescription NSAID (nonsteroidal ...

page 1 from 29